Literature DB >> 21282940

Serological profiles of urate, paraoxonase-1, ferritin and lipid in Parkinson's disease: changes linked to disease progression.

Ken Ikeda1, Yoshikazu Nakamura, Tetsuhito Kiyozuka, Joe Aoyagi, Takehisa Hirayama, Riya Nagata, Hirono Ito, Konosuke Iwamoto, Kiyoko Murata, Yasuhiro Yoshii, Kiyokazu Kawabe, Yasuo Iwasaki.   

Abstract

BACKGROUND: Oxidative stress plays a role in the pathogenesis of neuronal death. Serum levels of urate or lipid were associated with the incidence of Parkinson's disease (PD).
OBJECTIVE: We compared urate, paraoxonase-1 (PON1), iron, ferritin and lipid in sera of 119 PD patients and 120 healthy controls matched by age, sex and body mass index. We aimed to elucidate whether those serological data are correlated with disease progression.
RESULTS: Mean age (SD) of PD patients was 73.4 (8.7) years. Mean Yahr stage (SD) was 3.2 (0.9). Mean disease duration (SD) was 6.9 (5.1) years. Mean dose of L-DOPA (SD) was 355 (157) mg/day. As compared to controls, serum levels of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), urate and PON1 activity were significantly reduced, and serum ferritin levels were significantly increased in male and female PD patients. Serum urate levels and PON1 activities were inversely related, and serum ferritin levels were correlated with Yahr stage and PD duration in men and women. Serum levels of TC and LDL-C were inversely related to Yahr stage or PD duration in female patients.
CONCLUSIONS: Our studies indicated serological profiles of urate, PON1, ferritin, TC and LDL-C in PD patients. These serological changes were linked to PD progression. Metabolism of lipid, oxidant- and antioxidant-related substances may contribute to the pathogenesis and the progression of PD.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21282940     DOI: 10.1159/000323265

Source DB:  PubMed          Journal:  Neurodegener Dis        ISSN: 1660-2854            Impact factor:   2.977


  19 in total

Review 1.  HDL and cognition in neurodegenerative disorders.

Authors:  David A Hottman; Dustin Chernick; Shaowu Cheng; Zhe Wang; Ling Li
Journal:  Neurobiol Dis       Date:  2014-08-13       Impact factor: 5.996

2.  Does apolipoprotein A1 predict microstructural changes in subgenual cingulum in early Parkinson?

Authors:  Farzaneh Rahmani; Mohammad Hadi Aarabi
Journal:  J Neurol       Date:  2017-02-06       Impact factor: 4.849

Review 3.  The relevance of gender in Parkinson's disease: a review.

Authors:  Marina Picillo; Alessandra Nicoletti; Vincenza Fetoni; Barbara Garavaglia; Paolo Barone; Maria Teresa Pellecchia
Journal:  J Neurol       Date:  2017-01-04       Impact factor: 4.849

4.  HDL and Oxidation.

Authors:  Qi Zhang; Zongzhe Jiang; Yong Xu
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

5.  Genotypic-Phenotypic Analysis, Metabolic Profiling and Clinical Correlations in Parkinson's Disease Patients from Tamil Nadu Population, India.

Authors:  Dhivya Venkatesan; Mahalaxmi Iyer; Robert Wilson S; Arul Narayanasamy; Siva Kamalakannan; Abilash Valsala Gopalakrishnan; Balachandar Vellingiri
Journal:  J Mol Neurosci       Date:  2022-06-08       Impact factor: 2.866

6.  Plasma apolipoprotein A1 as a biomarker for Parkinson disease.

Authors:  Judy K Qiang; Yvette C Wong; Andrew Siderowf; Howard I Hurtig; Sharon X Xie; Virginia M-Y Lee; John Q Trojanowski; Dora Yearout; James B Leverenz; Thomas J Montine; Matt Stern; Susan Mendick; Danna Jennings; Cyrus Zabetian; Ken Marek; Alice S Chen-Plotkin
Journal:  Ann Neurol       Date:  2013-08-06       Impact factor: 10.422

7.  Serum lipid profile of Parkinson's disease patients: A study from the Northwest of Iran.

Authors:  Samira Saedi; Mohsen Hemmati-Dinarvand; Haleh Barmaki; Zohreh Mokhtari; Hadis Musavi; Mohamad Valilo; Ali Mota; Soleiman Mahjoub
Journal:  Caspian J Intern Med       Date:  2021-03

8.  Serum cholesterol and nigrostriatal R2* values in Parkinson's disease.

Authors:  Guangwei Du; Mechelle M Lewis; Michele L Shaffer; Honglei Chen; Qing X Yang; Richard B Mailman; Xuemei Huang
Journal:  PLoS One       Date:  2012-04-17       Impact factor: 3.240

9.  Serum uric acid levels in patients with Alzheimer's disease: a meta-analysis.

Authors:  Xueping Chen; Xiaoyan Guo; Rui Huang; Yongping Chen; Zhenzhen Zheng; Huifang Shang
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240

10.  Plasma Prolidase Activity and Oxidative Stress in Patients with Parkinson's Disease.

Authors:  Akhilesh Kumar Verma; Janak Raj; Vivek Sharma; Tej Bali Singh; Shalabh Srivastava; Ragini Srivastava
Journal:  Parkinsons Dis       Date:  2015-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.